Shareholder Value and Financial Outlook

Reconciliation of GAAP to non-GAAP financial measures Shareholders' net income and diluted earnings per share Three Months Ended December 31, 2022 Dollars in millions Pre-Tax Diluted earnings per share Dollars in millions Diluted earnings per share Pre-Tax After-Tax After-Tax $1,169 $3.83 Shareholders' net income Adjustments to reconcile to adjusted income from operations: Net realized investment (gains)* $(8) $(0.03) $(12) $(0.04) Amortization of acquired $457 $1.50 $284 $0.93 intangible assets Special items Integration and transaction-related costs $23 $0.08 $17 $0.06 Loss on sale of business $73 $0.23 $56 $0.18 Adjusted income from operations $1,514 $4.96 *Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. Confidential, unpublished property of Cigra. © 2023 Cigna

View entire presentation